Search

everythinglearnresearchcommunity

for

Search:↓

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Non-immune factors play a significant role in alopecia areata.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Thymic stromal lymphopoietin (TSLP) promotes hair growth, especially after skin injury.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

CD2 might be a new treatment target for patchy alopecia areata.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Liposomes could improve how skin care products work but are costly and not very stable.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.